Deception and Fraud in the Justification of “Pediatric Drug Development”: A Challenge at the Interface of Medicine and Law
J Law Med. 2024 Nov;31(3):635-644. ABSTRACT United States and European Union laws demand separate clinical studies in children as a condition for drugs’ marketing approval. …